Medivation, Inc. Announces Participation at Upcoming Investor Conference

SAN FRANCISCO, CA--(Marketwire - March 06, 2013) - Medivation, Inc. (NASDAQ: MDVN) today announced that it will present at the following conference:

  • Patrick Machado, chief business and financial officer, will present at the Barclays Global Healthcare Conference on March 12 at 1:30pm ET in Miami, FL.

About Medivation

Medivation, Inc. is a biopharmaceutical company focused on the rapid development of novel therapies to treat serious diseases for which there are limited treatment options. Medivation aims to transform the treatment of these diseases and offer hope to critically ill patients and their families. For more information, please visit us at www.medivation.com.


Contacts:
Patrick Machado
Chief Business & Financial Officer
(415) 829-4101

Anne Bowdidge
Sr. Director, Investor Relations
(650) 218-6900

Back to news